Description
Book SynopsisTrade Review"The book is one of the best bedside references of neuro-oncology that I have come across. Clinical pearls and case-based teaching are some of its unique features." -© Doody's Review Service, 2021, Sridhar S. Yaddanapudi, MD (Thomas Jefferson University) Doody's Score: 100 - 5 Stars!
Table of Contents1. Fundamentals of Neuropathology 2. Basics Principles of Neurosurgical Management of Tumor Patients 3. Radiation Oncology for the Neurologist 4. Evidence-Based Approaches to Chemotherapy for Brain Tumors 5. Emerging Non-pharmacologic Therapies for CNS Tumors 6. Evaluation of a Dural-Based Lesion 7. Evaluation of a Supratentorial Parenchymal Lesion 8. Evaluation of an Infratentorial Lesions (pediatric and adult) 9. Evaluation of Spinal Lesions 10. Evaluation of Peripheral Nerve Lesions 11. Approach to the Meningioma Patient 12. Approach to the Low-Grade Glioma Patient 13. Approach to the High-Grade Glioma Patient 14. Approach to a Brain Metastasis Patient 15. Approach to Leptomeningeal Metastasis Patient 16. Approach to the Patient with Neurofibromatosis: including NF1, NF2 and schwannomatosis 17. Approach to the Patient with Tuberous Sclerosis: including pediatrics and adult 18. Approach to Von Hippel Lindau, Cowden and Other Inherited Conditions 19. Central Nervous System Paraneoplastic Neurological Syndromes 20. Peripheral Nervous System Paraneoplastic Neurological Syndromes 21. Cancer-Associated Perineural Invasion 22. Cancer-Associated Plexopathy 23. Cancer Complications in Patients with Hematologic Malignancies 24. Approach to the Patient with Radiation Necrosis 25. Approach to Radiation Induced Neurocognitive Dysfunction (Beamo-Brain) 26. Uncommon Radiation Induced Neurological Syndromes 27. Approach to the Patient with Acute Chemotherapy Associated CNS Neurotoxicity 28. Approach to the Patient with a Chronic, Delayed Leukoencephalopathy 29. Approach to Chemotherapy Induced Peripheral Neuropathy 30. Approach to Neurocognitive Dysfunction Arising after Chemotherapy (Chemo-Brain) 31. Complications Associated with Immune Checkpoint Therapy 32. Complications Associated with CAR T-cell Therapy
